Calbryte Ca Ion Indicator
Lab Reagents
Aat Bioquest Laboratories manufactures the calbryte ca ion indicator reagents distributed by Genprice. The Calbryte Ca Ion Indicator reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact AAT Bioquest. Other Calbryte products are available in stock. Specificity: Calbryte Category: Ca Group: Ion Indicator
Calbryte™ 520, potassium salt |
|||
| 20658 | AAT Bioquest | 10x50 ug | EUR 471.6 |
Calbryte™ 590, potassium salt |
|||
| 20706 | AAT Bioquest | 5x50 ug | EUR 367.2 |
Calbryte™ 590, potassium salt |
|||
| 20707 | AAT Bioquest | 1 mg | EUR 842.4 |
Calbryte™ 630, potassium salt |
|||
| 20727 | AAT Bioquest | 5x50 ug | EUR 367.2 |
Autoclave Indicator Tapes,19mm (3/4") |
|||
| LC3018-001 | GenDepot | roll | EUR 84 |
Autoclave Circle Indicator Labels,1/2" |
|||
| LC3019-001 | GenDepot | 5000/roll | EUR 313.2 |
CA/ Rat CA ELISA Kit |
|||
| ELA-E0875r | Lifescience Market | 96 Tests | EUR 1063.2 |
CA 074 |
|||
| A1926-1 | ApexBio | 1 mg | EUR 177.6 |
|
Description: CA-074, a specific cathepsin B inhibitor, also abolished the neurotoxic effects caused by Abeta42-activated BV2 cell [1]. Co-treatment of cultures with the cathepsin B inhibitors CA-074 or Z-FA-FMK suppressed the cytostatic effects of TPA and activation of pro-uPA [2]. |
|||
CA 074 |
|||
| A1926-10 | ApexBio | 10 mg | EUR 582 |
|
Description: CA-074, a specific cathepsin B inhibitor, also abolished the neurotoxic effects caused by Abeta42-activated BV2 cell [1]. Co-treatment of cultures with the cathepsin B inhibitors CA-074 or Z-FA-FMK suppressed the cytostatic effects of TPA and activation of pro-uPA [2]. |
|||
CA 074 |
|||
| A1926-25 | ApexBio | 25 mg | EUR 895.2 |
|
Description: CA-074, a specific cathepsin B inhibitor, also abolished the neurotoxic effects caused by Abeta42-activated BV2 cell [1]. Co-treatment of cultures with the cathepsin B inhibitors CA-074 or Z-FA-FMK suppressed the cytostatic effects of TPA and activation of pro-uPA [2]. |
|||
CA 074 |
|||
| A1926-5 | ApexBio | 5 mg | EUR 373.2 |
|
Description: CA-074, a specific cathepsin B inhibitor, also abolished the neurotoxic effects caused by Abeta42-activated BV2 cell [1]. Co-treatment of cultures with the cathepsin B inhibitors CA-074 or Z-FA-FMK suppressed the cytostatic effects of TPA and activation of pro-uPA [2]. |
|||
CA 074 |
|||
| A1926-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 518.4 |
|
Description: CA-074, a specific cathepsin B inhibitor, also abolished the neurotoxic effects caused by Abeta42-activated BV2 cell [1]. Co-treatment of cultures with the cathepsin B inhibitors CA-074 or Z-FA-FMK suppressed the cytostatic effects of TPA and activation of pro-uPA [2]. |
|||
CA 074 |
|||
| A1926-S | ApexBio | Evaluation Sample | EUR 97.2 |
|
Description: CA-074, a specific cathepsin B inhibitor, also abolished the neurotoxic effects caused by Abeta42-activated BV2 cell [1]. Co-treatment of cultures with the cathepsin B inhibitors CA-074 or Z-FA-FMK suppressed the cytostatic effects of TPA and activation of pro-uPA [2]. |
|||
CA-1001 |
|||
| B2669-25 | Biovision | 25mg | EUR 709.2 |
CA-1001 |
|||
| B2669-5 | Biovision | 5mg | EUR 223.2 |
CA-074 |
|||
| B2971-1 | Biovision | 1 mg | EUR 235.2 |
CA-074 |
|||
| B2971-5 | Biovision | 5 mg | EUR 764.4 |
